THE DIRECT MEDICAL COST FOR DIABETES MELLITUS (DM) RELATED COMPLICATIONS IN CHINA

Author(s)

Zheng Y1, Österle A2, Liu X1, Wu J11Tianjin University, Tianjin, China, 2Vienna University of Economics and Business, Vienna, Austria

OBJECTIVES: To estimate the direct medical cost for diabetes mellitus (DM) related complications in China. METHODS:   Data were obtained from a cross-sectional survey of 20 internists of endocrine and metabolism departments in 20 hospitals from September to November in 2011 in 9 cities of China. 11 internists worked in tier 3 hospitals and 9 worked in tier 2 hospitals. All the internists who are department director or deputy director were asked to give the average costs of complications treatment according to their clinical practice and retrospective medical records. The diabetes related complications considered in this study were classified into chronic complications (Cardiovascular disease, Cerebrovascular disease, Neuropathy, Retinopathy, Nephropathy, Peripheral vascular diseases and foot damage) and acute complications (Ketoacidosis and major hypoglycemic). The direct medical costs were reported as annual costs including hospitalization, daily medications and examinations for DM-related chronic complications and as event costs for DM-related acute ones. All costs were reported in 2011 US dollar using the exchange rate of 6.47 Chinese Yuan to 1 USD. RESULTS: The annual medical cost for DM related complications per patient with and without hospitalizations: Myocardial infarction $6248.32 and $2025.26; Angina $4707.12 and $1453.63; Congestive Heart Failure $3433.08 and $1009.18; Stroke $3214.74 and $1401.46; Peripheral vascular disease $3348.11 and $1301.34; Neuropathy $2226.86 and $854.38. Renal failure with Haemodialysis $11245.93 and Peritoneal dialysis $7802.03; Renal transplant $33772.50 with operation and $8934.27 for daily maintenance. The event cost for Retinopathy: Laser operation $296.79; Cataract operation $1313.56; Amputation $2072.22; Infected ulcer treatment: $3007.11; Ketoacidosis $1493.55; Major hypoglycemic $729.18. CONCLUSIONS: The medical costs for DM related complications are overwhelming compared with the costs of insulin and hypoglycemic agents especially for those diabetic patients with severe nephropathy. Considering the high prevalence of diabetes and its complications diabetes poses substantial economic burden to the whole society in China.

Conference/Value in Health Info

2012-09, ISPOR Asia Pacific 2012, Taipei, Taiwan

Value in Health, Vol. 15, No. 7 (November 2012)

Code

PDB22

Topic

Economic Evaluation

Topic Subcategory

Cost/Cost of Illness/Resource Use Studies

Disease

Diabetes/Endocrine/Metabolic Disorders

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×